Setting Release Specifications for In Vitro Testing of Controlled Release Dosage Forms Saturday, July 14 (Afternoon) Chaired by Bob Stagner, Patheon, U.S.A. This workshop will educate formulators, analytical scientists, QA/QC professionals, regulatory professionals, and nonclinical statisticians about approaches and relevant issues in the evolution of setting in vitro specifications from early development, scale-up, and registration scale manufacture and corresponding phase-appropriate limits for controlled release products. The attendees will gain insight into how phase and manufacturing-scale appropriate limits are applied and specifications are set and verified for controlled/modified release products. Advance registration and payment required. Early Regular/Onsite Workshop Price (by May 7, 2012) (after May 7, 2012) Regular $200 $225 $145 Student/Post-doc $125
Preserving and Enhancing Vision via Ophthalmic Drug Delivery Sunday, July 15 (Afternoon) Chaired by Charles Doillon, University of Laval, Canada, and Todd Hoare, McMaster University, Canada Whether you are actively involved in developing ophthalmic drug delivery vehicles or are interested to learn more about the unique complexities presented by the eye in controlled release applications, this workshop will bring together industrial researchers, clinicians, and research scientists to discuss the current state-of-the-art technology in ophthalmic drug delivery (at both the front and the back of the eye) and the opportunities and challenges for future developments. Advance registration and payment required. Early Regular/Onsite Workshop Price (by May 7, 2012) (after May 7, 2012) Regular $200 $225 $145 Student/Post-doc $125
continued www.controlledreleasesociety.org/meetings/annual 17